secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2022-08-02T23:59:59+00:00
Accession:  0001628908-22-000093
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.02, 2.03, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health Q2 revenue up 44% to $319.9M; closes IPG acquisition
-------------------------------------------------------------------

- Revenue of $319.9M, +44.1% YoY; Adjusted EBITDA of $21.7M (6.8% margin).
- Net loss attributable to common shareholders of $4.6M.
- Total Lives on Platform 21.9M as of June 30, 2022.
- Added 4 new operating partnerships, including Molina Healthcare and a midwestern BCBS plan.
- Closed acquisition of Implantable Provider Group (IPG), financed with $175M term loan and $50M revolver.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890822000093/0001628908-22-000093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890822000093/evh-20220801.htm
  HTML page:      https://secwatch.observer/filing/0001628908-22-000093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer